Modalis Therapeutics Corporation
4883 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 中央区日本橋本町三丁目１１番５号
- Website:
- https://modalistx.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Modalis Therapeutics Corporation is a Japanese biotechnology company at the forefront of epigenome editing, dedicated to revolutionizing the treatment of genetic disorders. Utilizing its proprietary CRISPR-GNDM® technology, Modalis offers a novel approach to selectively target and regulate gene expression without altering the underlying DNA sequence. This advancement allows for precise modifications to the epigenome, restoring balance and addressing various diseases. With a robust pipeline that includes both in-house and collaborative development strategies, the company focuses on creating therapeutics for conditions such as muscular disorders, cardiomyopathy, and central nervous system (CNS) disorders. Committed to the belief that every life deserves attention, Modalis is poised to make significant contributions to the field of gene therapy.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Modalis Therapeutics Corporation.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-03-28 07:52 |
Regulatory News Service
臨時報告書
|
Japanese | 28.4 KB | |
| 2025-03-27 08:32 |
Regulatory News Service
内部統制報告書－第9期(2024/01/01－2024/12/31)
|
Japanese | 24.1 KB | |
| 2025-03-27 08:30 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-03-27 08:29 |
Annual Report
有価証券報告書－第9期(2024/01/01－2024/12/31)
|
Japanese | 2.1 MB | |
| 2025-02-21 07:31 |
Regulatory News Service
臨時報告書
|
Japanese | 21.5 KB | |
| 2024-08-13 08:14 |
Regulatory News Service
訂正有価証券届出書（組込方式）
|
Japanese | 293.9 KB | |
| 2024-08-13 07:58 |
Interim Report
半期報告書－第9期(2024/01/01－2024/12/31)
|
Japanese | 249.6 KB | |
| 2024-08-13 07:58 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-08-07 08:01 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 495.2 KB | |
| 2024-05-14 06:00 |
Quarterly Report
四半期報告書－第9期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 166.1 KB | |
| 2024-05-14 06:00 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-04-05 08:51 |
Regulatory News Service
確認書
|
Japanese | 8.8 KB | |
| 2024-04-05 08:41 |
Regulatory News Service
訂正有価証券報告書－第8期(2023/01/01－2023/12/31)
|
Japanese | 1.3 MB | |
| 2024-03-29 06:29 |
Regulatory News Service
臨時報告書
|
Japanese | 28.0 KB | |
| 2024-03-27 06:40 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB |
Automate Your Workflow. Get a real-time feed of all Modalis Therapeutics Corporation filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Modalis Therapeutics Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
